AzTrials
AzTrials

Coronary Artery DiseaseNCT07871188

Association Between Intraoperative Pulse Pressure Variation and Postoperative Lactate Clearance in Cardiac Surgery

An observational study of Coronary Artery Disease, run by Elzem SEN at 1 site in Turkey (Türkiye).

Recruiting

Looking for participants now. Contact the study team or a site below to ask about taking part.

Sites and contacts
Official record
Search all trials

Trial summary

This study aims to evaluate the relationship between intraoperative pulse pressure variation (PPV) and postoperative lactate clearance in adult patients undergoing elective cardiac surgery. Read more about this study

Who is it for?
Ages 18 to 80 years
Conditions the study is for
Coronary Artery Disease
What is being tested?
No Study-Specific Intervention
How many people
100 participants
Where
1 siteTurkey (Türkiye)
Study dates
2 Oct 2026to 15 Apr 2027
Phase
Observational
Are there results?
Not yet: the study is under way

Key requirements

Who can take part, as listed by the sponsor. Only the study team can confirm whether you are eligible, so take this list to your doctor.

  • Ages 18 to 80 years
  • All sexes
  • No healthy volunteers
  • Adult, Older adult

Study population: The study population will consist of adult patients aged 18-80 years undergoing elective coronary artery bypass graft surgery at Gaziantep University Hospital. Eligible patients will receive invasive arterial blood pressure monitoring and mechanical ventilation during surgery and will be admitted to the intensive care unit postoperatively. Patients meeting the inclusion and exclusion criteria will be consecutively enrolled. Intraoperative pulse pressure variation and postoperative blood lactate concentrations will be recorded as part of routine clinical care.

Who may be able to join

  • Adults aged 18-80 years.
  • Patients undergoing elective coronary artery bypass graft (CABG) surgery.
  • Patients receiving invasive arterial blood pressure monitoring and mechanical -ventilation during surgery.
  • Patients planned for postoperative admission to the intensive care unit.
  • Patients whose informed consent has been obtained.

Who cannot join

  • Patients with cardiac arrhythmias that may interfere with PPV measurement, such as atrial fibrillation.
  • Patients with severe aortic regurgitation.
  • Patients undergoing emergency cardiac surgery.
  • Patients receiving off-pump CABG.
  • Patients requiring spontaneous breathing or low tidal volume ventilation (<6 mL/kg) during PPV measurement.
  • Patients with missing or insufficient intraoperative hemodynamic or postoperative lactate measurements.

Trial locations and contacts

1 site in 1 country. Contact the study team or a site near you to ask about taking part.

ELZEM ŞEN, MD contact

+905327842151

drelzemsen@gmail.com

Turkey (Türkiye)1 site, 1 recruiting
  • Gaziantep University Hospital

    Gaziantep

    ELZEM ŞEN, MD, +90 532 784 2151, drelzemsen@gmail.com

    Recruiting

Other trials in Turkey (Türkiye)

About this study

Official title: Evaluation of the Relationship Between Intraoperative Pulse Pressure Variation and Postoperative Lactate Clearance in Patients Undergoing Cardiac Surgery

This study aims to evaluate the relationship between intraoperative pulse pressure variation (PPV) and postoperative lactate clearance in adult patients undergoing elective cardiac surgery. Intraoperative PPV values will be recorded, and blood lactate levels will be measured at admission to the intensive care unit and at 6 and 12 hours postoperatively. The study will investigate whether intraoperative PPV is associated with postoperative lactate clearance. This is a prospective observational study, and no additional interventions will be performed beyond routine clinical care.

Read the detailed description

This prospective observational cohort study will be conducted in adult patients aged 18-80 years undergoing elective coronary artery bypass graft surgery at Gaziantep University Hospital.

Intraoperative pulse pressure variation (PPV) will be recorded during surgery. Blood lactate levels will be measured at admission to the intensive care unit (0 hours) and at 6 and 12 hours postoperatively to assess lactate clearance.

The primary objective is to evaluate the relationship between intraoperative PPV and postoperative lactate clearance. The study will also explore the association between PPV and postoperative lactate clearance categories.

Patients with conditions that may affect the reliability of PPV measurements, including cardiac arrhythmias, spontaneous breathing, low tidal volume ventilation, and severe aortic regurgitation, will be excluded. Emergency surgeries and cases with missing essential hemodynamic or lactate data will also be excluded.

All measurements will be obtained as part of routine clinical care. No additional invasive procedures or study-specific interventions will be performed.

Being tested
No Study-Specific Intervention
Keywords
Pulse Pressure Variation, PPV, Lactate Clearance, Cardiac Surgery, Coronary Artery Bypass Graft, Postoperative Lactate
Medical subject headings
Coronary Artery Disease

What participants receive

What participants receive. In a randomised study each person is assigned to one group by chance.

  • No Study-Specific InterventionOther

    This is a prospective observational study. No study-specific intervention will be performed. All measurements will be obtained as part of routine clinical care.

Study groups in NCT07871188
Study groupRoleWhat they receive
Elective CABG CohortAdults aged 18-80 years undergoing elective coronary artery bypass graft surgery who meet the study eligibility criteria. Intraoperative pulse pressure variation and postoperative lactate levels will be assessed.
Receives: Other: No Study-Specific Intervention

What is being measured

The primary outcome is the main question the study is designed to answer.

  1. Association Between Intraoperative Pulse Pressure Variation and 12-Hour Postoperative Lactate Clearance

    The association between intraoperative pulse pressure variation (PPV) and postoperative lactate clearance at 12 hours after admission to the intensive care unit will be evaluated. Lactate clearance will be calculated as the percentage decrease in blood lactate concentration from ICU admission to 12 hours postoperatively.

    Measured: From ICU admission to 12 hours postoperatively

Secondary outcomes (2)
  1. 6-Hour Postoperative Lactate Clearance

    Percentage change in blood lactate concentration from admission to the intensive care unit to 6 hours postoperatively. Lactate clearance will be calculated as [(initial lactate - 6-hour lactate) / initial lactate] × 100.

    Measured: From ICU admission to 6 hours postoperatively

  2. Postoperative Lactate Clearance Categories

    Patients will be categorized according to postoperative lactate clearance as ≥20% or <20%, and the relationship between intraoperative pulse pressure variation and these categories will be evaluated.

    Measured: 12 hours postoperatively

Timeline

From the start of the study to its completion; the mark is today. Estimated dates are the sponsor’s plan.

  1. First posted13 Oct 2026
  2. Study start2 Oct 2026
  3. Primary completion1 Apr 2027 (estimated)
  4. Study completion15 Apr 2027 (estimated)

Resources

More details

For doctors and researchers: how the study is designed, who runs it, and its registry IDs.

Study design
Study type
Observational
Observational model
Cohort
Time perspective
Prospective
Enrolment
100 participants (estimated)
IDs, dates and publications
ClinicalTrials.gov ID
NCT07871188
Sponsor's protocol ID
2026/316
Status last verified
Oct 2026
First submitted
6 Oct 2026
Last updated
13 Oct 2026
Results posted
No
Data monitoring committee
No
FDA-regulated drug
No
FDA-regulated device
No
Individual data sharing
No: Individual participant data will not be shared with other researchers. Only aggregate study results may be reported in scientific publications. No individual-level data sharing is planned.

Publications

  • Zhou X, Pan W, Chen B, Xu Z, Pan J. Predictive performance of dynamic arterial elastance for arterial pressure response to fluid expansion in mechanically ventilated hypotensive adults: a systematic review and meta-analysis of observational studies. Ann Intensive Care. 2021 Jul 31;11(1):119. doi: 10.1186/s13613-021-00909-2.

    PubMed 34331607
  • Jones AE, Shapiro NI, Trzeciak S, Arnold RC, Claremont HA, Kline JA; Emergency Medicine Shock Research Network (EMShockNet) Investigators. Lactate clearance vs central venous oxygen saturation as goals of early sepsis therapy: a randomized clinical trial. JAMA. 2010 Feb 24;303(8):739-46. doi: 10.1001/jama.2010.158.

    PubMed 20179283
  • Ranucci M, De Toffol B, Isgro G, Romitti F, Conti D, Vicentini M. Hyperlactatemia during cardiopulmonary bypass: determinants and impact on postoperative outcome. Crit Care. 2006;10(6):R167. doi: 10.1186/cc5113.

    PubMed 17134504

Questions about this trial

What is this clinical trial studying?

An observational study of Coronary Artery Disease, run by Elzem SEN at 1 site in Turkey (Türkiye).

The full registered description is in the About this study section and the official record.

Who may be eligible to take part?

The sponsor lists 5 inclusion and 6 exclusion criteria. Eligibility is decided by the study team after screening, so read the full criteria and contact a listed site.

Is this clinical trial currently recruiting?

The record says: looking for participants now, as of the sponsor's last update on 13 Oct 2026. Status can change between updates, so confirm with the study contact before making plans.

Where is the study taking place?

The record lists 1 site in Turkey (Türkiye). Whether a site is taking part right now should be confirmed with that site. See every site.

What are the possible benefits and risks?

They depend on the study and the treatment, and no study can promise a benefit. The study team explains the known risks during informed consent, before anyone joins; the record itself does not list them.

Are results available for this study?

This study is still under way. Results are not available in the source record yet.

How can a doctor refer a patient or contact the research team?

Contact ELZEM ŞEN, MD (+905327842151, drelzemsen@gmail.com), or a site near the patient. AzTrials does not enrol participants or take referrals.

What does the primary outcome measure?

Association Between Intraoperative Pulse Pressure Variation and 12-Hour Postoperative Lactate Clearance (time frame: From ICU admission to 12 hours postoperatively). It is what the study was designed to measure, not a finding.

Where can I read the original study information?

On the ClinicalTrials.gov record for NCT07871188, which also lists 3 linked publications.

Does a listing mean the treatment is approved or proven to work?

No. A listing means the study is registered. It does not show that the treatment is safe, works, or is approved by a regulator.

How often is this information updated?

AzTrials copies changed records from ClinicalTrials.gov every night and reloads the whole registry every week. The sponsor last updated this record on 13 Oct 2026.

Free account

Log in to keep searching

You’ve used your 3 free searches. AzTrials is free: log in or create a free account to keep searching clinical trials and save the ones you want to follow.

Create a free accountLog in